Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by Rayzzeron Mar 22, 2018 11:03am

166 Views

Post# 27760896

RE:RE:where is wallace in korea

A bit of a connection with Pfizer. Dr. Chan did some key research on their product Celebrex.

As per the NR on May 12, 2017:

Antibe is pleased to announce that Dr. Francis Chan will serve as a key advisor in the upcoming Phase 2 GI safety study for ATB-346. Dr. Francis Chan is the Dean of Medicine at the Chinese University of Hong Kong and one of the most recognized and respected gastroenterologists in the world. Dr. Chan has particular expertise in the area of GI damage and bleeding caused by NSAIDs, and was the lead investigator of several very large, landmark clinical trials of Celebrex (which became the NSAID market leader by dollar volume at approximately $3 billion/year until patent expiry). Dr. Chan has published extensively in some of the world’s leading medical journals, including the New England Journal of Medicine and The Lancet

Goaweigh wrote: Aleve is owned by Bayer
Aspirin is owned by Bayer
Advil is owned by Pfizer
Motrin is owned by J&J

They are all going to be calling Wallace shortly and it's going to be a bidding war the likes of which the world has never seen before !!!